Skip to main content
Figure 1 | Respiratory Research

Figure 1

From: Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease

Figure 1

Experimental Study Design Scheme. BALB/c mice were immunized intraperitoneally with 20 micrograms of Ovalbumin (OVA) on days 0 and 14. OVA was then nebulized daily as a challenge on days 21 to 26. Different groups of mice were treated with 20 minute nebulizations of vehicle, fluticasone 6,000 micrograms per ml, salmeterol 3,000 micrograms per ml, or the combination of fluticasone and salmeterol. These were dosed once daily from days 19 to 27 (9 doses).

Back to article page